Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
We applied the electrophoretic mobility test (EMT) to 117 patients. 49 patients suffered from gynecological malignant tumors of different types and eleven had a carcinoma in situ. 57 patients served as a control group, 26 of whom were clinically healthy volunteers and 31 had benign gynecological diseases. In the EMT all malignant cases had inhibition values of at least-5% or even more. All other tested persons, the so-called non-malignant or healthy cases, had an inhibition of less than -5% or even an acceleration of the tanned sheep erythrocytes stabilized with sulfosalicylic acid (ETS).
D000941:Antigens; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000276:immunology; D002464:Cell Migration Inhibition; D004586:Electrophoresis; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D008214:Lymphocytes / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology
D000941:Antigens; D004676:Myelin Basic Protein